Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
14.11
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:300452 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 173.06 | 173.17 | 119.42 | 161.54 | 130.71 | 89.25 |
Depreciation & Amortization | 53.41 | 53.41 | 50.69 | 38.78 | 36.06 | 34.68 |
Other Amortization | 1.01 | 1.01 | 0.48 | 0.28 | 0.13 | - |
Loss (Gain) From Sale of Assets | 0.96 | 0.96 | -0.11 | 0.01 | 0.27 | 0.12 |
Asset Writedown & Restructuring Costs | -5.72 | -5.72 | 39.13 | 1.02 | 0.01 | 8.97 |
Loss (Gain) From Sale of Investments | -13.44 | -13.44 | -16.25 | -19.05 | -5.11 | -7.83 |
Provision & Write-off of Bad Debts | - | - | -0 | 0.05 | -0.04 | -0.01 |
Other Operating Activities | 35.25 | 14.25 | 11.95 | 7.04 | -1.13 | -2.23 |
Change in Accounts Receivable | -53.12 | -53.12 | -96.59 | -42.25 | -98.58 | -28.04 |
Change in Inventory | -3.56 | -3.56 | 5.34 | -2.91 | -13.43 | -28.91 |
Change in Accounts Payable | 30.91 | 30.91 | -3.27 | -15.12 | 77.63 | 36.86 |
Change in Other Net Operating Assets | 0.28 | 0.28 | 0.07 | 0.26 | 0.9 | 3.84 |
Operating Cash Flow | 212.87 | 191.99 | 118.33 | 132.3 | 132.82 | 103.82 |
Operating Cash Flow Growth | 74.27% | 62.25% | -10.56% | -0.39% | 27.93% | 21.36% |
Capital Expenditures | -43.61 | -40.73 | -27.94 | -54.92 | -67.31 | -31.47 |
Sale of Property, Plant & Equipment | 0.14 | 0.47 | 0.55 | 0.1 | 0.69 | 0.55 |
Investment in Securities | -80 | - | -7 | -288.69 | -29.31 | 5 |
Other Investing Activities | 15.46 | 13.44 | 19.38 | 10.54 | 7.73 | 6.08 |
Investing Cash Flow | -108.01 | -26.82 | -15.01 | -332.98 | -88.21 | -19.84 |
Short-Term Debt Issued | - | - | 14.85 | - | 49.8 | 31.15 |
Long-Term Debt Issued | - | 15.02 | 32.22 | 338.88 | - | - |
Total Debt Issued | 14.01 | 15.02 | 47.08 | 338.88 | 49.8 | 31.15 |
Short-Term Debt Repaid | - | - | - | - | -41 | -40.1 |
Long-Term Debt Repaid | - | -16.24 | -50.52 | -49.57 | - | - |
Total Debt Repaid | -9.01 | -16.24 | -50.52 | -49.57 | -41 | -40.1 |
Net Debt Issued (Repaid) | 5 | -1.22 | -3.44 | 289.31 | 8.8 | -8.95 |
Repurchase of Common Stock | - | - | -22.51 | - | - | - |
Common Dividends Paid | -71.41 | -71.43 | -59.01 | -59.78 | -55.33 | -46.32 |
Other Financing Activities | 3.46 | 3.46 | -0.25 | -1.36 | -1.99 | - |
Financing Cash Flow | -62.95 | -69.19 | -85.21 | 228.17 | -48.52 | -55.27 |
Foreign Exchange Rate Adjustments | -1.95 | -0.57 | 1.22 | -0.01 | 2.56 | -0.28 |
Net Cash Flow | 39.97 | 95.4 | 19.33 | 27.47 | -1.35 | 28.43 |
Free Cash Flow | 169.27 | 151.26 | 90.39 | 77.38 | 65.5 | 72.35 |
Free Cash Flow Growth | 87.63% | 67.34% | 16.82% | 18.13% | -9.46% | 12.71% |
Free Cash Flow Margin | 17.70% | 16.04% | 10.24% | 9.22% | 9.30% | 11.73% |
Free Cash Flow Per Share | 0.70 | 0.63 | 0.39 | 0.32 | 0.28 | 0.31 |
Cash Income Tax Paid | 64.41 | 59.57 | 58.72 | 15.47 | 40.46 | 40.42 |
Levered Free Cash Flow | 175.04 | 163.08 | 25.89 | 53.49 | 114.88 | 45.79 |
Unlevered Free Cash Flow | 175.04 | 163.08 | 33.85 | 56.18 | 115.64 | 46.54 |
Change in Working Capital | -31.66 | -31.66 | -86.99 | -57.37 | -28.09 | -19.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.